Investor Alert

Aug. 17, 2021, 1:29 a.m. EDT

Fully Automated Coagulometer Market Growth Powered with Latest Development Scenario| Erba Group, F Hoffmann-La Roche Ltd, Grifols SA, HemoSonics LLC, Abbott Laboratories

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Aug 17, 2021 (Market Insight Reports) -- This report studies the Fully Automated Coagulometer market in many aspects of the industry such as market size, market conditions, market trends and forecasts, and the report also provides brief information on competitors and specific growth opportunities with key market drivers. To provide, find complete Fully Automated Coagulometer market analysis segmented by company, region, type and application in the report.

The report provides regional analysis and valuable insights into the progress of the Fully Automated Coagulometer market and approaches related to the Fully Automated Coagulometer market. The report talks about the dominant aspects of the market and examines each segment.

According to World Federation of Haemophilia data, in 2018, around 210,454 people worldwide were diagnosed with haemophilia. Moreover, von willebrand disease prevalent cases were accounted to be approximately 78,547 and other bleed disorders were around 4

Get a Free sample copy of the Fully Automated Coagulometer market report


Top Companies in the Fully Automated Coagulometer Market- Abbott Laboratories, Erba Group, F Hoffmann-La Roche Ltd, Grifols SA, HemoSonics LLC, Haemonetics Corporation, Horiba, Instrumentation Laboratory, Siemens Healthcare, Sysmex and other.

(exclusive offer:Flat 20% discount on this report)

1.Company Profile

  1. Business Segments Analysis

  2. Financial Analysis

  3. SWOT analysis & Porter's Five Forces Analysis

  4. Possible Impact of COVID- 19 on Latest Market Conditions (Drivers, Restraints, Trends and Opportunities)

Industry News and Updates:The increasing number of hospitals and its developing infrastructure is increasing the demand for fully automated coagulometer devices. According to the American Hospital Association, there are around 5,198 community hospitals in the United States. Furthermore, according to Centers for Medicare & Medicaid Services, the government of United States spent around 4.6% more in 2018 than the preceding year for improving the healthcare infrastructure.

– Also, the increasing adoption of point of care testing by hospitals due to its rapid diagnosis and results, is expected to fuel the demand of fully automated coagulometer.

Key Market Trends:Product launches and strategic alliance by companies is expected to drive the fully automated analyzer market growth. In 2017, Instrument Laboratory acquired Accriva Diagnostics for extending its product line into point of care diagnostics of coagulation and anti-platelet therapy. Furthermore, in 2018, Horiba introduced fully automated coagulometers, Yumizen G800 for laboratories and Yumizen G1550 for clinical laboratories with high workload. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are HemoSonics LLC, Siemens Healthcare, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Erba Group, Sysmex, Instrumentation Laboratory, Horiba, Haemonetics Corporation and Grifols SA

Read Full Fully Automated Coagulometer Market Report (Description, TOC, List of Tables & Figures, and Many More) at:


Geographic Coverage-The report contains detailed country-level analysis, market revenue, market value and forecast analysis of ingestion, revenue and Fully Automated Coagulometer Market share, growth speed, historical and forecast (2015-2026) of these regions are covered:

-North America (the United States, Canada, and Mexico)

-Europe (Germany, France, UK, Russia, and Italy)

-Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.